SVRA Savara Inc
Nasdaq · SEC CIK 1160308 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $2.36M 2 sales by 2 insiders
- Filings on record
- 119 since 2021-08-18, latest 2026-07-24 18:24
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Lowrance David L | CFO | — | $2.24M |
| RAMSAY DAVID A | Dir | — | $121.2K |
| Wasfi Yasmine | Chief Medical Off | — | — |
| McCabe Kathleen R. | CLO | — | — |
| Erickson Anne | Chief Business Off | — | — |
| van Es-Johansson An | Dir | — | — |
| Lutz Robert Matthew | Chief Fin, Operating Off | — | — |
| McCracken Joseph S | Dir | — | — |
| Pauls Matthew | CEO, Dir | — | — |
| Elam Nevan C | Dir | — | — |
Transactions 127
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-07-24 18:24 | 2026-07-15 | SVRA | Lutz Robert Matthew | Chief Fin, Operating Off | A - Grant | $0.00 | +35.0K | 329.0K | +12% | $0 |
| DM | 2026-06-22 20:18 | 2026-06-22 | SVRA | Lowrance David L | CFO | M - OptEx | $1.76 | +580.2K | 983.9K | +144% | +$1.02M |
| DM | 2026-06-22 20:18 | 2026-06-22 | SVRA | Lowrance David L | CFO | F - Tax | $5.50 | -185.7K | 930.6K | -17% | -$1.02M |
| D | 2026-06-22 20:18 | 2026-06-22 | SVRA | Lowrance David L | CFO | S - Sale+OE | $5.68 | -394.5K | 536.0K | -42% | -$2.24M |
| DM | 2026-03-20 | 2026-03-18 | SVRA | Lowrance David L | CFO | M - OptEx | $1.60 | +366.7K | 417.6K | +722% | +$588.5K |
| DM | 2026-03-20 | 2026-03-18 | SVRA | Lowrance David L | CFO | F - Tax | $5.04 | -116.8K | 342.6K | -25% | -$588.5K |
| D | 2026-02-17 | 2026-02-16 | SVRA | McCracken Joseph S | Dir | M - OptEx | $1.76 | +1,807 | 302.6K | +0.6% | +$3,180 |
| 2025-12-19 | 2025-12-19 | SVRA | RAMSAY DAVID A | Dir | S - Sale | $6.06 | -20.0K | 2.53M | -0.8% | -$121.2K | |
| 2025-12-16 | 2025-12-14 | SVRA | McCabe Kathleen R. | CLO | F - Tax | $6.92 | -39.4K | 519.2K | -7% | -$272.3K | |
| 2025-12-16 | 2025-12-14 | SVRA | Lutz Robert Matthew | COO | F - Tax | $6.92 | -67.8K | 294.0K | -19% | -$468.9K | |
| 2025-12-16 | 2025-12-16 | SVRA | Lowrance David L | CFO | G - Gift | $0.00 | -32.0K | 286.0K | -10% | $0 | |
| 2025-12-16 | 2025-12-14 | SVRA | Lowrance David L | CFO | F - Tax | $6.92 | -63.0K | 318.0K | -17% | -$435.7K | |
| 2025-12-16 | 2025-12-16 | SVRA | Pauls Matthew | CEO, Dir | G - Gift | $0.00 | -129.0K | 1.19M | -10% | $0 | |
| 2025-12-16 | 2025-12-14 | SVRA | Pauls Matthew | CEO, Dir | F - Tax | $6.92 | -195.7K | 1.32M | -13% | -$1.35M | |
| 2025-12-16 | 2025-12-14 | SVRA | Erickson Anne | Chief Business Off | F - Tax | $6.92 | -63.0K | 371.7K | -14% | -$435.7K | |
| 2025-12-11 | 2025-12-10 | SVRA | Pauls Matthew | CEO, Dir | G - Gift | $0.00 | -23.6K | 1.51M | -2% | $0 | |
| 2025-12-11 | 2025-12-09 | SVRA | Hawkins Richard J | Dir | A - Grant | $0.00 | +40.0K | 161.3K | +33% | $0 | |
| 2025-12-11 | 2025-12-09 | SVRA | McCracken Joseph S | Dir | A - Grant | $0.00 | +40.0K | 300.8K | +15% | $0 | |
| 2025-12-11 | 2025-12-09 | SVRA | van Es-Johansson An | Dir | A - Grant | $0.00 | +40.0K | 102.5K | +64% | $0 | |
| 2025-12-11 | 2025-12-09 | SVRA | RAMSAY DAVID A | Dir | A - Grant | $0.00 | +40.0K | 2.55M | +2% | $0 | |
| 2025-12-11 | 2025-12-09 | SVRA | Elam Nevan C | Dir | A - Grant | $0.00 | +40.0K | 106.9K | +60% | $0 | |
| D | 2025-12-04 | 2025-12-02 | SVRA | Elam Nevan C | Dir | F - Tax | $5.81 | -1,473 | 66.9K | -2% | -$8,558 |
| D | 2025-12-04 | 2025-12-02 | SVRA | Elam Nevan C | Dir | M - OptEx | $1.46 | +5,860 | 68.4K | +9% | +$8,556 |
| 2025-12-04 | 2025-12-04 | SVRA | Wasfi Yasmine | Chief Medical Off | F - Tax | $6.37 | -22.0K | 168.0K | -12% | -$140.1K | |
| D | 2025-11-17 | 2025-11-14 | SVRA | Hawkins Richard J | Dir | M - OptEx | $1.46 | +5,860 | 121.3K | +5% | +$8,556 |
| D | 2025-10-22 | 2025-10-20 | SVRA | Wasfi Yasmine | Chief Medical Off | A - Grant | $0.00 | +35.0K | 190.0K | +23% | $0 |
| 2025-06-23 | 2025-06-20 | SVRA | Hawkins Richard J | Dir | P - Purchase | $2.04 | +48.2K | 115.5K | +72% | +$98.4K | |
| 2025-06-02 | 2025-05-29 | SVRA | McCracken Joseph S | Dir | P - Purchase | $2.08 | +10.0K | 260.8K | +4% | +$20.8K | |
| 2025-04-01 | 2025-03-31 | SVRA | RAMSAY DAVID A | Dir | P - Purchase | $2.78 | +150.0K | 2.51M | +6% | +$417.0K | |
| 2025-02-14 | 2025-02-13 | SVRA | Lutz Robert Matthew | COO | F - Tax | $2.83 | -38.3K | 361.7K | -10% | -$108.3K | |
| 2024-12-16 | 2024-12-12 | SVRA | RAMSAY DAVID A | Dir | A - Grant | $0.00 | +40.0K | 2.36M | +2% | $0 | |
| D | 2024-12-16 | 2024-12-13 | SVRA | Pauls Matthew | CEO, Dir | F - Tax | $3.21 | -92.6K | 1.59M | -5% | -$297.2K |
| D | 2024-12-16 | 2024-12-16 | SVRA | Pauls Matthew | CEO, Dir | S - Sale | $3.31 | -54.7K | 1.54M | -3% | -$181.1K |
| D | 2024-12-16 | 2024-12-12 | SVRA | Pauls Matthew | CEO, Dir | A - Grant | $0.00 | +400.0K | 1.68M | +31% | $0 |
| D | 2024-12-16 | 2024-12-12 | SVRA | Lutz Robert Matthew | COO | A - Grant | $0.00 | +100.0K | 400.0K | +33% | $0 |
| D | 2024-12-16 | 2024-12-12 | SVRA | Erickson Anne | Chief Business Off | A - Grant | $0.00 | +100.0K | 452.9K | +28% | $0 |
| D | 2024-12-16 | 2024-12-13 | SVRA | Erickson Anne | Chief Business Off | F - Tax | $3.21 | -18.3K | 434.7K | -4% | -$58.6K |
| 2024-12-16 | 2024-12-12 | SVRA | Elam Nevan C | Dir | A - Grant | $0.00 | +40.0K | 62.5K | +178% | $0 | |
| 2024-12-16 | 2024-12-12 | SVRA | McCracken Joseph S | Dir | A - Grant | $0.00 | +40.0K | 250.8K | +19% | $0 | |
| 2024-12-16 | 2024-12-16 | SVRA | Hawkins Richard J | Dir | S - Sale | $3.32 | -8,000 | 67.2K | -11% | -$26.6K | |
| 2024-12-16 | 2024-12-12 | SVRA | Hawkins Richard J | Dir | A - Grant | $0.00 | +40.0K | 75.2K | +114% | $0 | |
| D | 2024-12-16 | 2024-12-12 | SVRA | Pratt Raymond Dennis | Chief Medical Off | A - Grant | $0.00 | +80.0K | 340.1K | +31% | $0 |
| D | 2024-12-16 | 2024-12-12 | SVRA | Lowrance David L | CFO | A - Grant | $0.00 | +100.0K | 442.4K | +29% | $0 |
| D | 2024-12-16 | 2024-12-16 | SVRA | Lowrance David L | CFO | S - Sale | $3.33 | -25.0K | 381.0K | -6% | -$83.2K |
| D | 2024-12-16 | 2024-12-13 | SVRA | Lowrance David L | CFO | F - Tax | $3.21 | -24.4K | 406.0K | -6% | -$78.2K |
| D | 2024-12-16 | 2024-12-13 | SVRA | Lowrance David L | CFO | G - Gift | $0.00 | -12.0K | 430.4K | -3% | $0 |
| 2024-12-16 | 2024-12-12 | SVRA | van Es-Johansson An | Dir | A - Grant | $0.00 | +40.0K | 62.5K | +178% | $0 | |
| D | 2024-12-16 | 2024-12-12 | SVRA | Parker Braden C. | Chief Commercial Off | A - Grant | $0.00 | +20.0K | 105.0K | +24% | $0 |
| 2024-11-20 | 2024-11-19 | SVRA | McCracken Joseph S | Dir | P - Purchase | $2.95 | +20.0K | 210.8K | +10% | +$59.0K | |
| 2024-11-18 | 2024-11-18 | SVRA | RAMSAY DAVID A | Dir | P - Purchase | $2.88 | +100.0K | 2.32M | +4% | +$288.0K | |
| 2024-11-12 | 2024-11-10 | SVRA | Pratt Raymond Dennis | Chief Medical Off | F - Tax | $3.97 | -50.0K | 260.1K | -16% | -$198.3K | |
| 2024-10-22 | 2024-10-21 | SVRA | Erickson Anne | Chief Business Off | F - Tax | $3.57 | -381 | 352.9K | -0.1% | -$1,360 | |
| D | 2024-09-27 | 2024-09-25 | SVRA | Parker Braden C. | Chief Commercial Off | A - Grant | $0.00 | +85.0K | 85.0K | New | $0 |
| 2024-07-22 | 2024-07-21 | SVRA | Erickson Anne | Chief Business Off | F - Tax | $4.47 | -381 | 353.3K | -0.1% | -$1,703 | |
| 2024-04-23 | 2024-04-21 | SVRA | Erickson Anne | Chief Business Off | F - Tax | $4.81 | -381 | 353.7K | -0.1% | -$1,833 | |
| 2023-12-29 | 2023-12-28 | SVRA | Lowrance David L | CFO | S - Sale | $4.71 | -10.0K | 342.4K | -3% | -$47.1K | |
| 2023-12-29 | 2023-12-28 | SVRA | Pauls Matthew | CEO, Dir | S - Sale | $4.71 | -84.0K | 1.30M | -6% | -$395.6K | |
| 2023-12-29 | 2023-12-28 | SVRA | Pauls Matthew | CEO, Dir | G - Gift | $0.00 | -19.0K | 1.28M | -1% | $0 | |
| DM | 2023-12-29 | 2023-12-28 | SVRA | Elam Nevan C | Dir | M - OptEx | $1.30 | +53.8K | 116.3K | +86% | +$69.7K |
| D | 2023-12-29 | 2023-12-28 | SVRA | Elam Nevan C | Dir | S - Sale+OE | $4.71 | -93.8K | 22.5K | -81% | -$442.0K |
| D | 2023-12-18 | 2023-12-14 | SVRA | Pratt Raymond Dennis | Chief Medical Off | A - Grant | $0.00 | +150.0K | 310.0K | +94% | $0 |
| 2023-12-15 | 2023-12-14 | SVRA | RAMSAY DAVID A | Dir | A - Grant | $0.00 | +22.5K | 2.22M | +1% | $0 | |
| D | 2023-12-15 | 2023-12-14 | SVRA | Lowrance David L | CFO | A - Grant | $0.00 | +160.0K | 372.4K | +75% | $0 |
| D | 2023-12-15 | 2023-12-14 | SVRA | Lowrance David L | CFO | F - Tax | $4.45 | -30.4K | 212.4K | -13% | -$135.4K |
| D | 2023-12-15 | 2023-12-15 | SVRA | Lowrance David L | CFO | G - Gift | $0.00 | -20.0K | 352.4K | -5% | $0 |
| 2023-12-15 | 2023-12-14 | SVRA | Elam Nevan C | Dir | A - Grant | $0.00 | +22.5K | 62.6K | +56% | $0 | |
| 2023-12-15 | 2023-12-14 | SVRA | McCracken Joseph S | Dir | A - Grant | $0.00 | +22.5K | 190.8K | +13% | $0 | |
| D | 2023-12-15 | 2023-12-14 | SVRA | Pauls Matthew | CEO, Dir | F - Tax | $4.45 | -109.7K | 936.7K | -10% | -$488.1K |
| D | 2023-12-15 | 2023-12-14 | SVRA | Pauls Matthew | CEO, Dir | A - Grant | $0.00 | +450.0K | 1.39M | +48% | $0 |
| 2023-12-15 | 2023-12-14 | SVRA | Hawkins Richard J | Dir | A - Grant | $0.00 | +22.5K | 35.2K | +177% | $0 | |
| 2023-12-15 | 2023-12-14 | SVRA | van Es-Johansson An | Dir | A - Grant | $0.00 | +22.5K | 22.5K | New | $0 | |
| D | 2023-12-15 | 2023-12-14 | SVRA | Lutz Robert Matthew | COO | A - Grant | $0.00 | +160.0K | 300.0K | +114% | $0 |
| 2023-12-15 | 2023-12-14 | SVRA | Sun Ricky | Dir | A - Grant | $0.00 | +22.5K | 22.5K | New | $0 | |
| D | 2023-12-12 | 2023-12-11 | SVRA | Hawkins Richard J | Dir | M - OptEx | $0.82 | +10.8K | 12.7K | +571% | +$8,890 |
| D | 2023-12-12 | 2023-12-11 | SVRA | Elam Nevan C | Dir | M - OptEx | $0.82 | +10.8K | 40.1K | +37% | +$8,890 |
| I | 2023-07-19 | 2023-07-17 | SVRA | BASKETT FOREST | 10% | P - Purchase | $3.00 | +333.3K | 24.47M | +1% | +$1000.0K |
| I | 2023-07-19 | 2023-07-17 | SVRA | Walker Paul Edward | 10% | P - Purchase | $3.00 | +333.3K | 24.47M | +1% | +$1000.0K |
| I | 2023-07-19 | 2023-07-17 | SVRA | Mathers Edward T | 10% | P - Purchase | $3.00 | +333.3K | 24.47M | +1% | +$1000.0K |
| I | 2023-07-19 | 2023-07-17 | SVRA | Behbahani Ali | 10% | P - Purchase | $3.00 | +333.3K | 24.47M | +1% | +$1000.0K |
| 2023-07-19 | 2023-07-17 | SVRA | NEA 17 GP, LLC | 10% | P - Purchase | $3.00 | +333.3K | 24.47M | +1% | +$1000.0K | |
| I | 2023-07-19 | 2023-07-17 | SVRA | Chang Carmen | 10% | P - Purchase | $3.00 | +333.3K | 24.47M | +1% | +$1000.0K |
| I | 2023-07-19 | 2023-07-17 | SVRA | Florence Anthony A. Jr. | 10% | P - Purchase | $3.00 | +333.3K | 24.47M | +1% | +$1000.0K |
| I | 2023-07-19 | 2023-07-17 | SVRA | Yang Rick | 10% | P - Purchase | $3.00 | +333.3K | 24.47M | +1% | +$1000.0K |
| I | 2023-07-19 | 2023-07-17 | SVRA | Makhzoumi Mohamad | 10% | P - Purchase | $3.00 | +333.3K | 24.47M | +1% | +$1000.0K |
| I | 2023-07-19 | 2023-07-17 | SVRA | SANDELL SCOTT D | 10% | P - Purchase | $3.00 | +333.3K | 24.47M | +1% | +$1000.0K |
| 2023-06-27 | 2023-06-26 | SVRA | Pratt Raymond Dennis | Chief Medical Off | P - Purchase | $2.93 | +6,500 | 160.0K | +4% | +$19.0K | |
| M | 2023-05-26 | 2023-05-24+ | SVRA | RAMSAY DAVID A | Dir | P - Purchase | $2.59 | +100.0K | 2.15M | +5% | +$258.7K |
| D | 2023-02-28 | 2023-02-24 | SVRA | Lutz Robert Matthew | COO | A - Grant | $0.00 | +140.0K | 140.0K | New | $0 |
| M | 2023-01-03 | 2022-12-29+ | SVRA | RAMSAY DAVID A | Dir | P - Purchase | $1.55 | +36.0K | 2.07M | +2% | +$55.7K |
| M | 2022-12-28 | 2022-12-23+ | SVRA | RAMSAY DAVID A | Dir | P - Purchase | $1.45 | +19.0K | 2.06M | +0.9% | +$27.6K |
| M | 2022-12-22 | 2022-12-20+ | SVRA | RAMSAY DAVID A | Dir | P - Purchase | $1.48 | +45.0K | 2.05M | +2% | +$66.6K |
| 2022-12-22 | 2022-12-22 | SVRA | Pratt Raymond Dennis | Chief Medical Off | P - Purchase | $1.54 | +3,500 | 153.5K | +2% | +$5,390 | |
| M | 2022-12-20 | 2022-12-16+ | SVRA | RAMSAY DAVID A | Dir | P - Purchase | $1.49 | +54.9K | 2.00M | +3% | +$81.9K |
| D | 2022-12-15 | 2022-12-13 | SVRA | Elam Nevan C | Dir | M - OptEx | $0.65 | +1,172 | 29.2K | +4% | +$761.80 |
| D | 2022-12-15 | 2022-12-13 | SVRA | Pauls Matthew | CEO, Dir | A - Grant | $0.00 | +325.0K | 1.05M | +45% | $0 |
| D | 2022-12-15 | 2022-12-13 | SVRA | Lowrance David L | CFO | A - Grant | $0.00 | +100.0K | 242.8K | +70% | $0 |
| D | 2022-12-08 | 2022-12-07 | SVRA | Hawkins Richard J | Dir | M - OptEx | $0.65 | +1,172 | 1,900 | +161% | +$761.80 |
| M | 2022-11-25 | 2022-11-22+ | SVRA | RAMSAY DAVID A | Dir | P - Purchase | $1.42 | +20.1K | 1.95M | +1% | +$28.6K |
| D | 2022-11-22 | 2022-11-21 | SVRA | Pratt Raymond Dennis | Chief Medical Off | A - Grant | $0.00 | +150.0K | 150.0K | New | $0 |
| M | 2022-11-21 | 2022-11-17+ | SVRA | RAMSAY DAVID A | Dir | P - Purchase | $1.37 | +50.0K | 1.89M | +3% | +$68.4K |
Purchase Sale Sale after option exercise All abbreviations